News
Kidney injury may be less among patients with chronic kidney disease and atrial fibrillation taking apixaban versus warfarin for anticoagulation, new research suggests.
Features, News
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.
News
No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants
News
Concomitant use of dabigatran with verapamil or diltiazem was found to be associated with an increased risk of bleeding in patients with normal kidney function, according to the findings of a recently published retrospective cohort study.
News
Key classes of cardiovascular medications are affected by marijuana, including statins, β-blockers.
News
Morning or evening administration makes no difference on time outside target INR range.
News
A recent review published in The Journal of Clinical Pharmacology summarizes the current literature evaluating the potential risks associated with concomitant use of cannabis and antiplatelet agents or anticoagulants.
News
Findings seen among older patients with incident atrial fibrillation receiving warfarin or apixaban
News
Past-year cannabis use disorder increased among those aged 12 to 17 years, those aged 26 years and older
News
Noninferiority not found compared with standard-intensity prophylaxis with hip or knee arthroplasty